Vimarsana
Biggest News Aggregation in the World

Structural Reform Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Reform Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Reform Fund Today - Breaking & Trending Today

Chinese biotech firm Immorna raises $100m in extended Series A rounds - Vimarsana News

Chinese biotech firm Immorna raises $100m in extended Series A rounds

Previous backers also re-upped in the round. 

Chinese battery separator maker Horizon joins unicorn club after $195m deal - Vimarsana News

Chinese battery separator maker Horizon joins unicorn club after $195m deal

The company offered a combined 19.68% of its shares to the consortium

Transcenta Completes $105M Crossover Financing - Vimarsana News

Transcenta Completes $105M Crossover Financing

Transcenta Holding Limited, a global biotherapeutics company with integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, completed a 105m USD crossover financing. China Structural Reform Fund led the financing round, participated by new investors including Country Garden Venture Capital, Qatar Investment Authority, and other prominent institutional investors. Existing investors including CCT China Merchants Fund, Lilly Asia Ventures, Teng Yue Partners, Sequoia Capital China and others also participated in this round. The proceeds from new fund...

Transcenta Closes $105 Million in Crossover Financing - Vimarsana News

Transcenta Closes $105 Million in Crossover Financing

Transcenta Closes $105 Million in Crossover Financing Published : Wednesday, December 23, 2020, 8:00 am ACROFAN=PRNewswire | mediainquiries@prnewswire.com | SNS HONG KONG and SUZHOU, China, and HANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the completion of a 105 million USD crossover financing. China Structural Reform Fund led the financing round, participated by new investors incl...